(Q53258385)

12 May 2018

title

The burden of scientific progress: growing inequalities in the delivery of cancer care. (English)

1 reference

12 May 2018

1 reference

Max Mano

1

1 reference

12 May 2018

publication date

1 January 2006

1 reference

12 May 2018

published in

Acta Oncologica

1 reference

12 May 2018

volume

45

1 reference

12 May 2018

issue

1

1 reference

12 May 2018

page(s)

84-86

1 reference

12 May 2018

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860500341181

10.1080/02841860500341181

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018